Drug Profile
NM 0161
Alternative Names: METXytocin; NM-0161Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Nanomerics
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for preclinical development in Unspecified in United Kingdom
- 28 Jul 2016 Preclinical trials in Undefined indication in United Kingdom (unspecified route)